A shifting of the CD4/CD8 ratio in favor of CD8 could also be confirmed by this group in a HFD model and by other investigators, when applying a MCD model of NASH for 4 or 6 weeks, respectively (Henning et al., 2013; Kroy et al., 2014b). Here, CD8A is linked to metabolic dysfunction-associated steatohepatitis.